Findings

What do systematic reviews say?

5 questions · 5 findings · 3 reviews · Skin

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 60%Low 2 · 40%Moderate 0 · 0%High 0 · 0%

Adverse events · bullous pemphigoid

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Adverse events at 1 year · bullous pemphigoid

1 finding from 1 review

Interventions for bullous pemphigoid 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Adverse events: severe · patients with cutaneous disease in systemic lupus erythematosus

Oral ciclosporin showed no clear difference in adverse events: severe compared with oral azathioprine (low certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 0.89 [0.48, 1.65]
1 study · 89 participants
Low

Adverse events: minor (hirsutism) · patients with cutaneous disease in systemic lupus erythematosus

Oral ciclosporin may leads to higher adverse events: minor (hirsutism) compared with oral azathioprine (low certainty).

1 finding from 1 review

Interventions for cutaneous disease in systemic lupus erythematosus 2021 · Cochrane Headline outcomes only
RR 9.83 [1.32, 72.95]
1 study · 89 participants
Low

Incidence of serious adverse events · adults with alopecia areata

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 154 participants
Very low